Identification
- Summary
Cinnamon is an extract from Cinnamon used in allergy testing.
- Generic Name
- Cinnamon
- DrugBank Accession Number
- DB10520
- Background
Cinnamon allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Cinnamon Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US 
Cinnamon Injection, solution 0.10 g/1mL Percutaneous ALK-Abello, Inc. 1998-02-23 Not applicable US Cinnamon Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Cinnamon Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Cinnamon Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Cinnamon Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Cinnamon Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Cinnamon Injection, solution 1 g/20mL Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1972-08-29 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image CHI. JOA (Anti-inflammatory effect, antibacterial effect, stomatitis improvement, plaque removal) Cinnamon (1 g/100g) + Levomenthol (1 g/100g) + Menthol (1 g/100g) + Myrrh (1 g/100g) + Pear (1 g/100g) + Peppermint (1 g/100g) + Sea salt (47 g/100g) + Silicon dioxide (1 g/100g) + Sorbitol (1 g/100g) + Xylitol (1 g/100g) Powder Topical BIOHERB Co., Ltd. 2023-07-11 2024-07-10 US Chungwidan-F Cinnamon (500 mg/30mL) + Ginger (300 mg/30mL) Liquid Oral Han Kook Shin Yak Pharmaceutical Co., Ltd. 2019-12-18 Not applicable US Chungwidan-F Cinnamon (500 mg/30mL) + Nutmeg (300 mg/30mL) Liquid Oral Lydia Co., Ltd. 2022-06-06 Not applicable US ซาน ซิออง หวัน Cinnamon (0.04 g) + Belladonna (900 mcg) + Clove (0.03 g) + Glycyrrhiza glabra (0.08 g) + Levomenthol (0.005 g) + Phenyl salicylate (0.02 g) + Wood creosote (0.015 ml) Pill บริษัท แมคโครฟาร์ จำกัด 2016-06-07 Not applicable Thailand 
ยาเม็ดตกเบ็ด 4. Cinnamon (0.03 g) + Belladonna (0.9 mg) + Clove (0.03 g) + Glycyrrhiza glabra (0.04 g) + Levomenthol (0.005 g) + Phenyl salicylate (0.02 g) + Wood creosote (0.015 ml) Pill ห้างหุ้นส่วนจำกัด ห้างขายยาลี้บ้วนซัว (ตราตกเบ็ด) 1987-03-11 Not applicable Thailand ยาเม็ดลี้บ้วนซัว (ตราตกเบ็ด) Cinnamon (1 mg) + Belladonna (3 mg) + Clove (3 mg) + Glycyrrhiza glabra (69 mg) + Levomenthol (2 mg) + Peppermint (30 mg) + Wood creosote (20 mg) Pill บริษัท ลี้บ้วนซัว ดิสเปนซารี่ (ห้างเก่า) จำกัด 2015-03-05 Not applicable Thailand ยาเม็ดสามหมี Cinnamon (2 mg) + Gambir (22.22 mg) + Glycyrrhiza glabra (16.67 mg) + Phellodendron amurense bark (33.33 mg) + Tangerine peel (33.33 mg) + Wood creosote (44.44 mg) Tablet, film coated ห้างหุ้นส่วนจำกัด แอล.บี.เอส. แลบบอเรตอรี่ 2011-05-23 2019-10-21 Thailand - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image CHI. JOA (Anti-inflammatory effect, antibacterial effect, stomatitis improvement, plaque removal) Cinnamon (1 g/100g) + Levomenthol (1 g/100g) + Menthol (1 g/100g) + Myrrh (1 g/100g) + Pear (1 g/100g) + Peppermint (1 g/100g) + Sea salt (47 g/100g) + Silicon dioxide (1 g/100g) + Sorbitol (1 g/100g) + Xylitol (1 g/100g) Powder Topical BIOHERB Co., Ltd. 2023-07-11 2024-07-10 US Chungwidan-F Cinnamon (500 mg/30mL) + Ginger (300 mg/30mL) Liquid Oral Han Kook Shin Yak Pharmaceutical Co., Ltd. 2019-12-18 Not applicable US Chungwidan-F Cinnamon (500 mg/30mL) + Nutmeg (300 mg/30mL) Liquid Oral Lydia Co., Ltd. 2022-06-06 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 5S29HWU6QB
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Powder Topical Liquid Oral Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous 0.10 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Capsule Oral Pill Tablet, film coated - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53